BioLabs
BioLabs operates a 21-site global network of shared laboratory and office facilities serving 440+ life science startups, with revenue from membership fees and a 60+ sponsor roster of major pharma and equipment manufacturers.
- Company typePrivate
- Founded2009
- HeadquartersSan Diego, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What BioLabs does
BioLabs operates a membership-based network of shared laboratory and office facilities designed for early-stage life science companies. Founded in 2009 by Johannes Fruehauf and headquartered in Cambridge, Massachusetts, the company provides fully equipped, turnkey lab infrastructure — including benches, private suites, shared equipment, and operational support — that allows biotech startups to begin experimental work within days rather than months. As of the input period, BioLabs operates 21 sites across five countries (United States, Canada, France, Germany, and Japan) on three continents, housing more than 440 resident companies that have collectively raised over $5 billion in venture capital.
The company's core product is a co-working lab real estate platform differentiated by centralized operations, standardized site design, and a multi-sided business model. BioLabs generates revenue through recurring membership fees paid by resident startups (per-bench and private-suite pricing tiers), supplemented by sponsorship revenue from a network of more than 60 pharmaceutical, biotechnology, and laboratory equipment companies — including AbbVie, Bristol-Myers Squibb, Sanofi, Pfizer, Daiichi Sankyo, Thermo Fisher, and Agilent. Sponsors gain curated access to the resident startup pipeline through programming such as the Golden Ticket award, pitch events, and dedicated innovation programs. Member companies benefit from flexible, low-commitment access to wet-lab infrastructure they could not otherwise afford as standalone facilities.
BioLabs has pursued an aggressive expansion strategy, opening or announcing sites in Philadelphia (March 2025), Paris-Saclay via a joint venture with Servier (June 2025), Berlin with Berlin Institute of Health (July 2025), Vermont (October 2025), Toronto at MaRS Discovery District (April 2026), and Rochester, Minnesota with Mayo Clinic (Fall 2026). These moves extend the network into new therapeutic verticals (advanced therapeutics, cell and gene therapy), new geographies (first Canadian and rural sites), and deeper academic/clinical integration. The platform operates with reported headcount in the 80-250 range depending on source, supporting centralized site operations, sponsorship management, and resident services.
BioLabs firmographics
Firmographics- Name
- BioLabs
- Legal name
- BioLabs
- Website
- https://biolabs.io
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- BioLabs operates a 21-site global network of shared laboratory and office facilities serving 440+ life science startups, with revenue from membership fees and a 60+ sponsor roster of major pharma and equipment manufacturers.
- Ownership category
- akta.pro rank
BioLabs industry classification
Industry- Product category
- Biotech Incubator Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Laboratory Apparatus & Furniture (3821), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Bioprocess Facility, Cleanroom & Utility Systems (HVAC, WFI, CIP/SIP, containment) (HLAAAJAJ)
- akta.pro secondary industries
- Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF), Process Development & Tech Transfer (Upstream/Downstream/MSAT) (HLAGAGAE)
Keywords
Where BioLabs is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices20 records
Markets served
BioLabs business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Infrastructure, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Membership Fees: BioLabs operates as a membership-based network where life science startups pay for access to shared lab facilities, office space, equipment, and the global network. Membership tiers offer varying levels of bench space, private labs, and graduate suites.
- Sponsorship Revenue: Pharmaceutical companies, biotech firms, and equipment manufacturers pay sponsorship fees for visibility, access to startups, and participation in the Golden Ticket program.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Single bench in shared open lab |
| Subscription | Monthly | Private graduate suites (23-bench) |
| Subscription | Annual | Golden Ticket Award |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
BioLabs product offering
Product offeringCore offering
BioLabs operates an international, membership-based network of shared laboratory and office co-working facilities for life science startups. Members pay recurring subscription fees for access to fully equipped lab bench space, private suites, shared scientific equipment, and operational support services across 21 sites in key biotech innovation clusters worldwide. The company supplements core facility rental with the BioLabs Marketplace procurement platform and the pharma-sponsored Golden Tickets Program offering complimentary membership and mentorship to winning startups.
Product overview
BioLabs is a membership-based international network of shared laboratory and office facilities for life science startups. The core offering includes fully equipped co-working lab spaces with shared equipment across 21 global locations. Key products and programs include: BioLabs Marketplace (an end-to-end cloud-based procurement platform with access to 1,000+ suppliers), the Golden Tickets Program (sponsored competition awarding free lab space and mentorship, with 50+ awarded globally), and specialized facilities like BioLabs for Advanced Therapeutics in Philadelphia (focused on cell and gene therapy with Thermo Fisher collaboration), BioLabs University of Toronto (first Canadian location in MaRS Discovery District), and Spartners at Paris-Saclay (co-founded with Servier). The network spans 3 continents, 5 countries, and supports over 440 resident companies that have collectively raised more than $5B.
Differentiator
Problem solved
Functional benefit
Brands
- Spartners: A premier biotech incubator located at Servier R&D center in Paris-Saclay, co-founded with Servier. Provides access to state-of-the-art laboratories, modular workspaces, and collaborative environment for startups.
- BioLabs Marketplace
- Golden Tickets
Products and services
- BioLabs Shared Lab & Office Facilities Membership-based shared laboratory and office co-working facilities for life science startups, providing shared equipment, modular workspaces from single bench to private suites, and collaborative environments in key biotech innovation clusters across the USA, Canada, France, Germany, and Japan.
- BioLabs Marketplace Cloud-based procurement platform enabling BioLabs member companies to purchase research tools and supplies from over 1,000 suppliers with pre-negotiated discounts, dedicated order support, and simplified billing.
- Golden Tickets Program Sponsorship competition program where pharma partners select winning biotech startups to receive one year of complimentary BioLabs membership, dedicated laboratory bench access, and mentorship from sponsor scientific leaders.
- BioLabs for Advanced Therapeutics Specialized incubator facility in Philadelphia focused on advanced therapeutics including cell therapy, gene therapy, and related technologies. Features 30,000 sq ft expansion with specialized support labs, process development equipment, and Thermo Fisher's Advanced Therapies Collaboration Center.
- BioLabs University of Toronto 40,000-square-foot shared laboratory and office facility located in Toronto's MaRS Discovery District, BioLabs' first Canadian location, supporting over 30 early-stage life science startups with access to global investor networks and industry partners.
- Spartners by Servier & BioLabs Premier biotech incubator at Paris-Saclay co-founded with Servier, offering over 110 lab benches across coworking and private spaces. Provides access to Servier's network of 2,000 researchers and world-class scientific resources.
- BioLabs Rochester MN 16,000 sq ft state-of-the-art co-working laboratory facility at Discover Sq. in Rochester's medical district, developed in collaboration with Mayo Clinic to accelerate HealthTech innovation.
- BioLabs Watertown 21,000 sq ft state-of-the-art co-working facility near Boston/Cambridge biotech cluster, MBTA accessible, offering flexible lab and office spaces for biotech startups.
- BioLabs San Diego Premier co-working space for life science startups in San Diego, co-founded with Biocom, featuring specialized lab and office facilities designed for startups to test, develop, and grow biotech innovations.
- Princeton Innovation Center BioLabs Co-working environment in New Jersey's academic community, in partnership with Princeton University, offering shared office and lab space with strategic access to capital and industry partners for early-stage life science companies.
- BioLabs Tokyo BioLabs facility at Shinkiba in Tokyo Bay, part of Mitsui Fudosan's R&D hub, established in collaboration with LINK-J to support Japanese life science startups with access to global networks.
- BioLabs Pegasus Park (North Texas) 37,000 sq ft flexible co-working lab and office facilities located on the 23-acre Pegasus Park campus in Dallas, enabling collaboration and entrepreneurship throughout the North Texas area.
Quantifiable outcome
- Member companies have collectively raised over $5B in funding
- +5 more outcomes
Companies that use BioLabs
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles4 records
BioLabs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
BioLabs partnerships and signals
Strategic signalPartnerships
18 partnerships are on record, tiered flagship, core, founding and strategic.
- AbbVieflagshipAbbVie is a founding sponsor of BioLabs University of Toronto and has expanded its global partnership with BioLabs across multiple locations. The company sponsors the annual AbbVie Biotech Innovators Awards program providing winning recipients with free lab and office space, shared equipment, and mentorship. AbbVie also sponsors BioLabs Tokyo as founding sponsor and offers the AbbVie Japan Innovation Award Golden Ticket program.
- University of TorontoflagshipUniversity of Toronto partnered with BioLabs to launch Toronto's largest shared lab incubator at MaRS Discovery District. BioLabs took over a life sciences incubator space formerly supported by Johnson & Johnson, ensuring ongoing support for over 30 early-stage startups. This is BioLabs' first Canadian location.
- Thermo Fisher ScientificcoreThermo Fisher opened its second East Coast Advanced Therapies Collaboration Center (ATxCC) within BioLabs for Advanced Therapeutics in Philadelphia. The facility supports cell and gene therapy development by providing lab space, expertise, and collaboration opportunities to biotech and biopharma startups.
- Mayo ClinicfoundingMayo Clinic is the founding partner for BioLabs Rochester MN, coming Fall 2026. The 16,000 sq ft facility at Discover Sq. in the Rochester MN medical district will attract local, regional, and global entrepreneurial innovators seeking connections with Mayo Clinic's world-class scientific and healthcare excellence.
- University of VermontcoreBioLabs launched its first rural site in partnership with University of Vermont, aiming to fuel regional bioscience innovation outside major metropolitan areas.
- Berlin Institute of Health (BIH)coreBIH partnered with BioLabs to launch the BIH Clinical Incubator (CLIC) at Rahel Hirsch Center to support research teams and entrepreneurs in developing advanced therapies and personalized medical products. The incubator provides infrastructure, mentorship, and access to BioLabs' global network.
- ServierflagshipCo-founded Spartners by Servier & BioLabs at Paris-Saclay - a premier biotech incubator with over 110 lab benches. Servier provides access to 2,000+ researchers for mentorship and expert coaching. Grand opening celebrated June 11, 2025 after two years of supporting health innovation.
- BiocomfoundingBiocom is the founding partner of BioLabs San Diego, co-designing the premier co-working space for life science startups in Southern California.
- Mitsui FudosanfoundingMitsui Fudosan is developing the R&D hub where BioLabs Tokyo is located in Shinkiba, Tokyo. The partnership provides access to one of Japan's most strategically positioned innovation corridors.
- LINK-JfoundingLINK-J (Life Science Innovation Network Japan) partners with BioLabs to provide deep industry-government-academia connections for resident companies, bridging Japan's exceptional foundational research with real-world application.
- Princeton UniversityfoundingPrinceton University is the founding partner of Princeton Innovation Center BioLabs, nestled in New Jersey's academic community and part of the broader Princeton innovation ecosystem.
- Lundquist Institute for Biomedical InnovationcoreLundquist Institute is developing a 15-acre biotech park in partnership with Trammell Crow Co. to support companies graduating from its BioLabs incubator at the West Carson, California location.
- LabCentralstrategicBioLabs partnered with LabCentral for joint Golden Ticket programs in the Boston-Cambridge ecosystem. LabCentral has awarded over 150 Golden Tickets worth $7.5 million since 2017.
- MBC BioLabsstrategicBioLabs partnered with MBC BioLabs as part of the strategic partnership with AbbVie to boost innovation in key biotech clusters in the US and Europe.
- OBIO (Ontario Bioscience Innovation Organization)coreOBIO partnered with BioLabs - University of Toronto for the Entrepreneurship Training Program for Women in STEM, launching March 2026 to support 25-30 female innovators. OBIO also invested $100,000 in Block Biosciences through the WiHI Seed Program.
- Pegasus ParkfoundingPegasus Park is the host campus for BioLabs North Texas, providing the 23-acre reinvigorated campus location for the 37,000 sq ft facility.
- Charite (Berlin)coreBioLabs at Charite in Berlin serves the German life sciences ecosystem through partnership with Charite university hospital.
- NYU Langone HealthfoundingBioLabs at NYU Langone provides incubator space for life science startups in New York City in partnership with NYU Langone Health.
Scale indicators23 records
Recent moves11 records
Expansion highlights5 records
BioLabs competitors and assessment
Company assessmentBroad incumbents
- JLABS (Johnson & Johnson Innovation): Johnson & Johnson's global network of life science incubators operating across North America, Europe, and Asia. Larger-scale incumbent with similar no-strings-attached lab space model but tied to J&J's strategic priorities and broader innovation mandate.
- Alexandria LaunchLabs: Alexandria Real Estate's startup platform providing move-in-ready lab and office space, strategic capital, and operational support to early-stage life science companies. Backed by a major life science REIT, offers deeper real estate integration but less sponsor-pharma ecosystem focus than BioLabs.
Regional players
- MaRS Discovery District: Toronto-based innovation hub hosting BioLabs' University of Toronto location. Comparable as a multi-tenant life science and tech incubator with shared infrastructure, but operates as a broader tech/life science hub rather than a biotech-only coworking space.
- BioGenerator: St. Louis-based nonprofit life science startup accelerator and investor providing lab space, mentorship, and seed funding. Regional competitor with combined incubator/VC model serving a focused geographic market, with similar support services to early-stage biotech founders.
- CELL AND GENE THERAPY CATAPULT: UK-based innovation center for cell and gene therapy with large-scale manufacturing facilities and similar shared infrastructure model. Comparable to BioLabs' Advanced Therapeutics facility in Philadelphia, but operating in the UK with a more manufacturing-focused mandate.
Direct peers
- IndieBio: Biotech accelerator providing lab space, programming, and seed funding to biology startups. Direct peer focusing on biology-first companies with an accelerator/program structure layered on top of shared lab infrastructure (NY and SF).
- MBC BioLabs: San Carlos, CA-based shared lab and office facility for early-stage life science startups. Direct competitor with similar membership model, partnered with BioLabs through AbbVie for joint Golden Ticket competitions in the Bay Area biotech ecosystem.
- LabCentral: Cambridge, MA-based shared lab incubator for biotech startups, operating across multiple sites in the Kendall Square area. Most direct competitor to BioLabs with the same membership-based coworking model; notably founded by the same individual (Johannes Fruehauf) and operating a partnership/joint Golden Ticket program with BioLabs.
Emerging players
- CIC (Cambridge Innovation Center): Global shared workspace and innovation campus operator with growing life science lab offerings (CIC Labs). Comparable coworking/shared infrastructure model expanding into wet lab space, competing in adjacent verticals of the startup ecosystem.
- Petri (Biology-focused accelerator): Boston-based biotech accelerator and community platform. Emerging player providing early-stage programming and resources for biology startups, with a smaller physical footprint than BioLabs but overlapping target market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
BioLabs social profiles
Digital presenceBioLabs financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioLabs leadership team
Management profileNumber of profiles
Profiles10 records
BioLabs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioLabs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioLabs
What does BioLabs do?
BioLabs operates an international, membership-based network of shared laboratory and office co-working facilities for life science startups. Members pay recurring subscription fees for access to fully equipped lab bench space, private suites, shared scientific equipment, and operational support services across 21 sites in key biotech innovation clusters worldwide. The company supplements core facility rental with the BioLabs Marketplace procurement platform and the pharma-sponsored Golden Tickets Program offering complimentary membership and mentorship to winning startups.
Is BioLabs a public or private company?
BioLabs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BioLabs founded?
BioLabs was founded in 2009. It employs 101 to 250 people.
Where is BioLabs based?
BioLabs is headquartered in San Diego, United States, in the North America region.
How does BioLabs make money?
Two revenue lines are on record. Membership Fees are the primary driver. The others are sponsorship Revenue.
Who are BioLabs's main competitors?
Broad incumbents on record are JLABS (Johnson & Johnson Innovation) and Alexandria LaunchLabs. Regional players are MaRS Discovery District, BioGenerator and CELL AND GENE THERAPY CATAPULT. Direct peers are IndieBio, MBC BioLabs and LabCentral. Emerging players are CIC (Cambridge Innovation Center) and Petri (Biology-focused accelerator).
Does BioLabs have an API?
No public API is recorded for BioLabs.
What industry is BioLabs in?
BioLabs's product category is Biotech Incubator Services. Its primary akta.pro industry code is HLAAAJAJ, Bioprocess Facility, Cleanroom & Utility Systems (HVAC, WFI, CIP/SIP, containment), with a secondary code of HLAAAKAF, Process Development & Tech Transfer Services (upstream/downstream). Its NAICS code is 54171 and its SIC code is 3821.